Sana Biotechnology's total assets for Q3 2025 were $435.43M, an increase of 20.40% from the previous quarter. SANA total liabilities were $240.12M for the fiscal quarter, a 0.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.